Callan JMB expects up to $15 million in oral thin-film revenue in first 18 months of operation
CJMB•Callan JMB expects up to $15 million in oral thin-film manufacturing revenue during its first 18 months of operation after equipment qualification. Its QuickStrip production line has arrived at its Texas facility, and the projects do not require additional capital raising.
1. Production line arrives
The QuickStrip production line from Rapid Dose Therapeutics has arrived for installation at Callan JMB’s Texas facility. Callan JMB expects up to $15 million in oral thin-film manufacturing revenue during its first 18 months of operation following equipment qualification.
2. No additional capital raising
Callan JMB said neither the oral thin-film project nor its previously announced IV bag manufacturing facility requires additional capital raising.
